Trials / Conditions / Seborrheic Keratosis

Seborrheic Keratosis

19 registered clinical trials studyying Seborrheic Keratosis — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Effect of 1% Andaliman Fruit Extract Cream on Facial Seborrheic Keratosis NCT07334600	Universitas Sumatera Utara	N/A
Recruiting	A Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratosis NCT06108024	DermBiont, Inc.	Phase 2
Completed	Comparison of 3 in Vivo Microscopic Imaging Techniques for the Diagnosis of Pigmented Tumors NCT06046144	Centre Hospitalier Universitaire de Saint Etienne	—
Unknown	Adaptive Design Study for Safety and Efficacy of Treatment Regimens With SM-020 in Subjects With Seborrheic Ke NCT05136144	DermBiont, Inc.	Phase 2
Completed	Effectiveness of Sodium Fusidate Ointment Compared to Petrolatum for Wound Healing Following Cauterization NCT05353374	Indonesia University	N/A
Completed	Fast Track Diagnosis of Skin Cancer by Advanced Imaging NCT04229277	University Hospital Bispebjerg and Frederiksberg	N/A
Terminated	Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin Damage NCT04688749	Aristotle University Of Thessaloniki	—
Terminated	Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Optimization Study NCT04249115	Pulse Biosciences, Inc.	N/A
Completed	An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses NCT03487588	Aclaris Therapeutics, Inc.	Phase 4
Completed	A Randomized, Vehicle-Controlled Study of 2 Concentrations of A-101 for the Treatment of Seborrheic Keratosis NCT03148691	Aclaris Therapeutics, Inc.	Phase 2
Completed	Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Study NCT03846531	Pulse Biosciences, Inc.	N/A
Completed	A Study of A-101 Solution 40% in Subjects With Seborrheic Keratosis. NCT02667236	Aclaris Therapeutics, Inc.	Phase 3
Completed	An Open-Label Safety Study of A-101 Solution NCT02667288	Aclaris Therapeutics, Inc.	Phase 3
Completed	A Randomized, Double-Blind, Vehicle-Controlled Study in Subjects With Seborrheic Keratosis NCT02667275	Aclaris Therapeutics, Inc.	Phase 3
Completed	Study of A-101 for the Treatment of Seborrheic Keratosis NCT02260180	Aclaris Therapeutics, Inc.	Phase 2
Completed	Dose-Response Profile of A-101 in Subjects With Seborrheic Keratosis NCT02160626	Aclaris Therapeutics, Inc.	Phase 2
Completed	Study to Evaluate the Safety and Efficacy of PEP005(Ingenol Mebutate) Gel, 0.05%, in Patients With Seborrhoeic NCT01214564	Peplin	Phase 2
Completed	Is Cryosurgery or Curettage More Effective at Treating Seborrheic Keratoses? NCT01159860	Milton S. Hershey Medical Center	N/A
Completed	Optical Biopsy of Human Skin in Conjunction With Laser Treatment NCT00540566	University of California, Irvine	—